Skip to main content

Table 6 Univariate and multivariate analysis of disease-free survival of stage II CRC patients

From: Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer

Risk factors

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Age (> / ≤ 68, years)

2.119 (1.080–4.159)

0.029*

2.069 (1.053–4.066)

0.035*

Sex (female/male)

1.196 (0.638–2.244)

0.577

  

BMI (> / ≤ 23.4 kg/m2)

0.509 (0.264–0.984)

0.045*

0.523 (0.270–1.012)

0.054

Hypertension (yes/no)

1.110 (0.600–2.054)

0.739

  

Tumor site (colon/ rectum)

1.401 (0.733–2.676)

0.308

  

Vessel invasion (yes/no)

1.318 (0.180–9.658)

0.786

  

Adjuvant therapy (yes/no)

1.782 (0.425–7.473)

0.429

  

Smoking (yes/no)

0.859 (0.454–1.625)

0.641

  

Drinking (yes/no)

1.442 (0.728–2.857)

0.293

  

Family history (yes/no)

1.814 (0.558–5.895)

0.322

  

CHD (yes/no)

1.503 (0.526–4.294)

0.720

  

Overall complications (yes/no)

1.486 (0.797–2.771)

0.213

  

Major complications (yes/no)

2.951 (0.903–9.646)

0.073

  
  1. Note: *P-value < 0.05
  2. Abbreviations: CRC Colorectal cancer, HR Hazard ratio, CI Confidence interval, BMI Body mass index, CHD Coronary heart disease, TNM tumor nodes metastasis